STA
EDVA

Summit Trail Advisors’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Summit Trail Advisors’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Hold
25,000
– – ﹤0.01% 1473
2026
Q1 		$35.9K Buy
+25,000
New +$57.8K ﹤0.01% 1436

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Summit Trail Advisors's EDVA Position: Q2 2026 in Review

Summit Trail Advisors held its Endovia Health Sciences, Inc. (EDVA) position steady in Q2 2026 at 25,000 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Summit Trail Advisors first reported a position in EDVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $35.9K in Q1 2026. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Summit Trail Advisors held 25,000 shares of Endovia Health Sciences, Inc. worth $15.5K as of Q2 2026.
  • Summit Trail Advisors left its Endovia Health Sciences, Inc. share count unchanged in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1473 holding.
  • Summit Trail Advisors first reported a position in Endovia Health Sciences, Inc. in Q1 2026 and has held it in 2 quarters since.
  • Summit Trail Advisors's Endovia Health Sciences, Inc. position peaked at $35.9K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.